Leukomalacia, Periventricular
4
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
3 treatments under study, led by Red Blood Cell Transfusion Guidelines
Research Leaders
6 sponsors active, led by National Center for Research Resources (NCRR)
Related Conditions
Often studied with 13 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
S100B as a Marker of Brain Injury of Preterm Infants
Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants
Liberal Versus Restrictive Transfusion Guidelines for Preterm Infants
Research Network
Common Treatments
- Red Blood Cell Transfusion Guidelines1
- Normal Saline1
- Recombinant Human Erythropoietin Rhepo1
Active Sponsors
- National Center for Research Resources (NCRR)1
- National Institutes of Health (NIH)1
- University of Iowa1
- NICHD Neonatal Research Network1
- Sheba Medical Center1
Top Investigators
China Medical University Hospital
Children's Hospital Medical Center, Cincinnati
University of New Mexico
University of Iowa
University of Miami
Related Conditions
- Infant Premature3
- Intracranial Hemorrhages2
- Brain Injuries1
- Intraventricular Hemorrhage1
- Retinopathy Of Prematurity1